Curis, Inc. (CRIS)

0.4473 -0.02 (-4.85%) USD  |  NASDAQ  |  Jun 09, 14:43
More

Curis SG&A Expense (Quarterly) : 5.07M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for CRIS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Lineage Cell Therapeutics, Inc. 5.084M
Agenus, Inc. 6.86M
Amgen, Inc. 1.602B
BioCryst Pharmaceuticals, Inc. 94.55M
Imunon, Inc. 1.969M